Oral administration of kynurenic acid delays the onset of type 2 diabetes in Goto-Kakizaki rats

Kynurenic acid (KYNA) is an endogenous catabolite of tryptophan that has been found to demonstrate neuroprotective properties in psychiatric disorders. Recently, accumulating data have suggested that KYNA may also play a significant role in various metabolic diseases by stimulating energy metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhen, Delong, Ding, Lina, Wang, Bao, Wang, Xiaolei, Hou, Yanli, Ding, Wenyu, Portha, Bernard, Liu, Junjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328841/
https://www.ncbi.nlm.nih.gov/pubmed/37424591
http://dx.doi.org/10.1016/j.heliyon.2023.e17733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328841/
https://www.ncbi.nlm.nih.gov/pubmed/37424591
http://dx.doi.org/10.1016/j.heliyon.2023.e17733

Ejemplares similares